Refine
Has Fulltext
- yes (30)
Year of publication
Document Type
- Journal article (28)
- Doctoral Thesis (2)
Keywords
- frontotemporal dementia (2)
- strong coupling (2)
- two-dimensional materials (2)
- ADAM metallopeptidase with thrombospondin type 1 motif 5 (ADAMTS7) (1)
- ADHD (1)
- ADHD patients (1)
- AHRR (1)
- ALS treatment (1)
- Alien limb syndrome (1)
- Amyotrophic Lateral Sclerosis (ALS) (1)
- Amyotrophic Lateral Sclerosis Assessment Questionnaire 5 (ALSAQ-5) (1)
- Anarchic limb syndrome (1)
- Bose gas (1)
- Bose-Fermi (1)
- CD117 (1)
- CK5 (1)
- CNS cancer (1)
- CYP1B1 (1)
- Cancer (1)
- Corticobasal syndrome (1)
- Cytochrome P 450 pathway (1)
- Datenauswertung (1)
- Diagnosis prediction (1)
- Dünnschichtchromatographie (1)
- EGF Rezeptor (1)
- EGFR (1)
- EGFR Transactivation (1)
- ERBB receptors (1)
- EWAS (1)
- Epidermaler Wachstumsfaktor-Rezeptor (1)
- EuroQol Five Dimension Five Level Scale (EQ-5D-5L) (1)
- Expression (1)
- Fermi liquid (1)
- G-Protein gekoppelte Rezeptoren (1)
- GPCR (1)
- GWAS meta-analysis (1)
- HiGHmed (1)
- Krebs <Medizin> (1)
- LRIG1 (1)
- Malignant melanoma (1)
- Masticatory mucosa (1)
- Metalloprotease (1)
- Methylation (1)
- Microcavity devices (1)
- NT‐proBNP (1)
- OSCC (1)
- Quantifizierung (1)
- Quantum-well, -wire and -dot devices (1)
- RNA transport (1)
- RNA-binding proteins (1)
- Resonators (1)
- Scanner (1)
- Scattering (1)
- Skin cancer screening (1)
- Smoking (1)
- Stage distribution (1)
- Support vector machine (1)
- Survival analysis (1)
- TNM staging (1)
- Thin-layer chromatography (1)
- Transaktivierung (1)
- UV (1)
- Zuordnung (1)
- acute decompensated heart failure (1)
- affective disorders (1)
- alveolar bone loss (1)
- amyotrophic lateral sclerosis (ALS) (1)
- anxiety (1)
- aphasia (1)
- areas (1)
- assessment of cognitive disorders/dementia (1)
- assistive devices (1)
- atlas‐based volumetry (1)
- behavioral variant frontotemporal dementia (1)
- birth cohort (1)
- cancer (1)
- care tempis (1)
- caregiver burden (1)
- cavity device (1)
- childhood asthma (1)
- chromosome 11Q13 (1)
- clinical routine data (1)
- cognitive neuropsychology in dementia (1)
- coherent multidimensional spectroscopy (1)
- composite supraparticles (1)
- congestion (1)
- decreasing autonomy (1)
- depression (1)
- dermatitis (1)
- diagnostic criteria (1)
- disease progression (1)
- dye adsorption (1)
- early breast cancer (1)
- electrochemical conversion (1)
- exciton (1)
- executive function (1)
- filaggrin mutations (1)
- food allergy (1)
- functional status (1)
- gene ADGRL3 (1)
- gene × sex interaction (1)
- genetic risk (1)
- genome-wide association studies (GWAS) (1)
- genomewide association (1)
- hay fever (1)
- health-related quality of life (1)
- health-related quality of life (HRQoL) (1)
- heart failure (1)
- heritability (1)
- hiPSC (1)
- hospitals (1)
- iPSC (1)
- iPSCs (1)
- induced pluripotent stem cells (1)
- inferior vena cava (1)
- inflammation (1)
- informal caregiving (1)
- ischemic stroke (1)
- juvenile myoclonic epilepsy (1)
- laser spectroscopy (1)
- light-matter coupling (1)
- longitudinal magnetic resonance imaging (1)
- magnetic fields (1)
- magnetic particles (1)
- medical data integration center (1)
- medical informatics initiative (1)
- melanoma (1)
- mental disorders (1)
- microresonators (1)
- molecular neuroscience (1)
- mortality (1)
- mouse model (1)
- nanophotonics and plasmonics (1)
- oncology (1)
- openEHR (1)
- outcomes (1)
- paediatric cancer (1)
- pilot project (1)
- polaritons (1)
- primary progressive aphasia (1)
- prognosis (1)
- psychological support (1)
- quality (1)
- quality of life (QoL) (1)
- quantification (1)
- relation (1)
- risk (1)
- risk SNP rs1397547 (1)
- risk factors (1)
- risk prediction scores (1)
- sample size calculation (1)
- scanner (1)
- semantic interoperability (1)
- shared genetic basis (1)
- skin carcinogenesis (1)
- social cognition (1)
- socioeconomic status (1)
- stem cells (1)
- stimulated (1)
- symptom-specific treatment (1)
- theory of mind (1)
- therapy (1)
- thrombolysis (1)
- time (1)
- transition metal dichalcogenide (1)
- triple-negative breast cancer (1)
- two-dimensional (1)
- ultrasound (1)
- vesicle-associated membrane protein 8 (VAMP8) (1)
- volumetric MRI (1)
- water purification (1)
- zweidimensional (1)
- “bulbar-onset” ALS (bALS) (1)
- “limb-onset” ALS (lALS) (1)
Institute
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (6)
- Physikalisches Institut (5)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (3)
- Institut für Klinische Epidemiologie und Biometrie (3)
- Neurologische Klinik und Poliklinik (3)
- Theodor-Boveri-Institut für Biowissenschaften (3)
- Medizinische Klinik und Poliklinik II (2)
- Poliklinik für Zahnerhaltung und Parodontologie (2)
- Abteilung für Forensische Psychiatrie (1)
- Fakultät für Physik und Astronomie (1)
Sonstige beteiligte Institutionen
- Arizona State University, Tempe, Arizona, USA (1)
- Fraunhofer-Institute for Applied Optics and Precision Engineering IOF Jena, Germany (1)
- Friedrich Schiller University Jena, Germany (1)
- Max Planck School of Photonics Jena, Germany (1)
- National Institute for Materials Science, Tsukuba, Japan (1)
- Röntgen Center for Complex Material Systems (RCCM), Am Hubland, 97074 W¨urzburg, Germany (1)
- Servicezentrum Medizin-Informatik (1)
- University of Oldenburg, Germany (1)
- University of Science and Technology of China, Hefei, China (1)
Molecular-based subclassifications of breast cancer are important for identifying treatment options and stratifying the prognosis in breast cancer. This study aimed to assess the prognosis relative to disease-free survival (DFS) and overall survival (OS) in patients with triple-negative breast cancer (TNBC) and other subtypes, using a biomarker panel including cytokeratin 5 (CK5), cluster of differentiation 117 (CD117), and epidermal growth factor receptor (EGFR). This cohort–case study included histologically confirmed breast carcinomas as cohort arm. From a total of 894 patients, 572 patients with early breast cancer, sufficient clinical data, and archived tumor tissue were included. Using the immunohistochemical markers CK5, CD117, and EGFR, two subgroups were formed: one with all three biomarkers negative (TBN) and one with at least one of those three biomarkers positive (non-TBN). There were significant differences between the two biomarker subgroups (TBN versus non-TBN) in TNBC for DFS (p = 0.04) and OS (p = 0.02), with higher survival rates (DFS and OS) in the non-TBN subgroup. In this study, we found the non-TBN subgroup of TNBC lesions with at least one positive biomarker of CK5, CD117, and/or EGFR, to be associated with longer DFS and OS.
Aims
Treating patients with acute decompensated heart failure (ADHF) presenting with volume overload is a common task. However, optimal guidance of decongesting therapy and treatment targets are not well defined. The inferior vena cava (IVC) diameter and its collapsibility can be used to estimate right atrial pressure, which is a measure of right‐sided haemodynamic congestion. The CAVA‐ADHF‐DZHK10 trial is designed to test the hypothesis that ultrasound assessment of the IVC in addition to clinical assessment improves decongestion as compared with clinical assessment alone.
Methods and results
CAVA‐ADHF‐DZHK10 is a randomized, controlled, patient‐blinded, multicentre, parallel‐group trial randomly assigning 388 patients with ADHF to either decongesting therapy guided by ultrasound assessment of the IVC in addition to clinical assessment or clinical assessment alone. IVC ultrasound will be performed daily between baseline and hospital discharge in all patients. However, ultrasound results will only be reported to treating physicians in the intervention group. Treatment target is relief of congestion‐related signs and symptoms in both groups with the additional goal to reduce the IVC diameter ≤21 mm and increase IVC collapsibility >50% in the intervention group. The primary endpoint is change in N‐terminal pro‐brain natriuretic peptide from baseline to hospital discharge. Secondary endpoints evaluate feasibility, efficacy of decongestion on other scales, and the impact of the intervention on clinical endpoints.
Conclusions
CAVA‐ADHF‐DZHK10 will investigate whether IVC ultrasound supplementing clinical assessment improves decongestion in patients admitted for ADHF.
Background
Over the past two decades, there has been a rising trend in malignant melanoma incidence worldwide. In 2008, Germany introduced a nationwide skin cancer screening program starting at age 35. The aims of this study were to analyse the distribution of malignant melanoma tumour stages over time, as well as demographic and regional differences in stage distribution and survival of melanoma patients.
Methods
Pooled data from 61 895 malignant melanoma patients diagnosed between 2002 and 2011 and documented in 28 German population-based and hospital-based clinical cancer registries were analysed using descriptive methods, joinpoint regression, logistic regression and relative survival.
Results
The number of annually documented cases increased by 53.2% between 2002 (N = 4 779) and 2011 (N = 7 320). There was a statistically significant continuous positive trend in the proportion of stage UICC I cases diagnosed between 2002 and 2011, compared to a negative trend for stage UICC II. No trends were found for stages UICC III and IV respectively. Age (OR 0.97, 95% CI 0.97–0.97), sex (OR 1.18, 95% CI 1.11–1.25), date of diagnosis (OR 1.05, 95% CI 1.04–1.06), ‘diagnosis during screening’ (OR 3.24, 95% CI 2.50–4.19) and place of residence (OR 1.23, 95% CI 1.16–1.30) had a statistically significant influence on the tumour stage at diagnosis. The overall 5-year relative survival for invasive cases was 83.4% (95% CI 82.8–83.9%).
Conclusions
No distinct changes in the distribution of malignant melanoma tumour stages among those aged 35 and older were seen that could be directly attributed to the introduction of skin cancer screening in 2008.
"
Fanconi anemia (FA) is a genetically heterogeneous disorder with 22 disease-causing genes reported to date. In some FA genes, monoallelic mutations have been found to be associated with breast cancer risk, while the risk associations of others remain unknown. The gene for FA type C, FANCC, has been proposed as a breast cancer susceptibility gene based on epidemiological and sequencing studies. We used the Oncoarray project to genotype two truncating FANCC variants (p.R185X and p.R548X) in 64,760 breast cancer cases and 49,793 controls of European descent. FANCC mutations were observed in 25 cases (14 with p.R185X, 11 with p.R548X) and 26 controls (18 with p.R185X, 8 with p.R548X). There was no evidence of an association with the risk of breast cancer, neither overall (odds ratio 0.77, 95%CI 0.44–1.33, p = 0.4) nor by histology, hormone receptor status, age or family history. We conclude that the breast cancer risk association of these two FANCC variants, if any, is much smaller than for BRCA1, BRCA2 or PALB2 mutations. If this applies to all truncating variants in FANCC it would suggest there are differences between FA genes in their roles on breast cancer risk and demonstrates the merit of large consortia for clarifying risk associations of rare variants.
Evidence for a shared genetic basis of association between coronary artery disease (CAD) and periodontitis (PD) exists. To explore the joint genetic basis, we performed a GWAS meta-analysis. In the discovery stage, we used a German aggressive periodontitis sample (AgP-Ger; 680 cases vs 3,973 controls) and the CARDIoGRAMplusC4D CAD meta-analysis dataset (60,801 cases vs 123,504 controls). Two SNPs at the known CAD risk loci ADAMTS7 (rs11634042) and VAMP8 (rs1561198) passed the pre-assigned selection criteria (PAgP-Ger < 0.05; PCAD < 5 × 10−8; concordant effect direction) and were replicated in an independent GWAS meta-analysis dataset of PD (4,415 cases vs 5,935 controls). SNP rs1561198 showed significant association (PD[Replication]: P = 0.008 OR = 1.09, 95% CI = [1.02–1.16]; PD [Discovery + Replication]: P = 0.0002, OR = 1.11, 95% CI = [1.05–1.17]). For the associated haplotype block, allele specific cis-effects on VAMP8 expression were reported. Our data adds to the shared genetic basis of CAD and PD and indicate that the observed association of the two disease conditions cannot be solely explained by shared environmental risk factors. We conclude that the molecular pathway shared by CAD and PD involves VAMP8 function, which has a role in membrane vesicular trafficking, and is manipulated by pathogens to corrupt host immune defense.
Characterisation of Metalloprotease-mediated EGFR Signal Transactivation after GPCR Stimulation
(2011)
In the context of metalloprotease-mediated transactivation of the epidermal growth factor receptor, different monoclonal antibodies against ADAM17 / TACE were characterized for their ability to block the sheddase. Activity of some of them was observed at doses between 2µg/mL and 10µg/mL. Kinetic analyses showed their activity starting at around 30 minutes. In cellular assays performed with the antibodies, especially upon treatment of cells with sphingosine-1-phosphate a reduction in proliferation was observed with some candidates. Moreover this study provides potential new roles for ß-Arrestins. Their involvement in the triple membrane-passing signal pathway of EGFR transactivation was shown. Furthermore, in overexpressing cellular model systems, an interaction between ADAM17 and ß-Arrestin1 could be observed. Detailed analysis discovered that phosphorylation of ß-Arrestin1 is crucial for this interaction. Additionally, the novel mechanism of UV-induced EGFR transactivation was extended to squamous cell carcinoma. The mechanism happens in a dose dependent manner and requires a metalloprotease to shed the proligand Amphiregulin. The involvement of both ADAM9 and ADAM17, being the metalloproteases responsible for this cleavage, was shown for SCC9 cells.
Electro-optical switching between polariton and cavity lasing in an InGaAs quantum well microcavity
(2014)
We report on the condensation of microcavity exciton polaritons under optical excitation in a microcavity with four embedded InGaAs quantum wells. The polariton laser is characterized by a distinct nonlinearity in the input-output-characteristics, which is accompanied by a drop of the emission linewidth indicating temporal coherence and a characteristic persisting emission blueshift with increased particle density. The temporal coherence of the device at threshold is underlined by a characteristic drop of the second order coherence function to a value close to 1. Furthermore an external electric field is used to switch between polariton regime, polariton condensate and photon lasing.
The possibility of investigating macroscopic coherent quantum states in polariton condensates and of engineering polariton landscapes in semiconductors has triggered interest in using polaritonic systems to simulate complex many-body phenomena. However, advanced experiments require superior trapping techniques that allow for the engineering of periodic and arbitrary potentials with strong on-site localization, clean condensate formation, and nearest-neighbor coupling. Here we establish a technology that meets these demands and enables strong, potentially tunable trapping without affecting the favorable polariton characteristics. The traps are based on a locally elongated microcavity which can be formed by standard lithography. We observe polariton condensation with non-resonant pumping in single traps and photonic crystal square lattice arrays. In the latter structures, we observe pronounced energy bands, complete band gaps, and spontaneous condensation at the M-point of the Brillouin zone.
Eczema often precedes the development of asthma in a disease course called the 'atopic march'. To unravel the genes underlying this characteristic pattern of allergic disease, we conduct a multi-stage genome-wide association study on infantile eczema followed by childhood asthma in 12 populations including 2,428 cases and 17,034 controls. Here we report two novel loci specific for the combined eczema plus asthma phenotype, which are associated with allergic disease for the first time; rs9357733 located in EFHC1 on chromosome 6p12.3 (OR 1.27; P = 2.1 x 10(-8)) and rs993226 between TMTC2 and SLC6A15 on chromosome 12q21.3 (OR 1.58; P = 5.3 x 10(-9)). Additional susceptibility loci identified at genome-wide significance are FLG (1q21.3), IL4/KIF3A (5q31.1), AP5B1/OVOL1 (11q13.1), C11orf30/LRRC32 (11q13.5) and IKZF3 (17q21). We show that predominantly eczema loci increase the risk for the atopic march. Our findings suggest that eczema may play an important role in the development of asthma after eczema.
Computerunterstützte Auswertung in der automatisierten zweidimensionalen Dünnschichtchromatographie
(2002)
Die vorliegende Arbeit beschäftigt sich mit der zweidimensionalen Dünnschichtchromatographie (DC) und deren quantitativer Auswertung. Es wird auf die Grundlagen der DC eingegangen. Darüberhinaus werden die Vorgehensweisen der quantitativen Auswertung gegenübergestellt und bewertet. Besonders behandelt werden die nichtlinearen Regressionsmethoden. Die in dieser Arbeit verwendete Entwicklungstechnik wird erklärt und die Vorteile beschrieben. Der im Rahmen dieser Arbeit entwickelte Scanner und die dazugehörige Software werden vorgestellt. Als Lichtquelle dient eine 30 W Deuteriumlampe, die ohne Sperrfilter betrieben wird. Dies ermöglicht die Verwendung von Licht auch im Bereich von 198-210 nm. Auf einen Betrieb der Lichtquelle im Vakuum wurde verzichtet. Die Einblendtechnik der Lichtstrahlen in den Lichtwellenleiter wurde nicht verändert. Der bewegliche Teil des Scanners besteht aus einem Kreuztisch, dessen Vorschubeinheiten um 90° versetzt angebracht wurden, um die Platte in x- und in y-Richtung bewegen zu können. Die Wahl der Spindelsteigung ermöglicht eine Schrittweite von 0.1 mm im Bedarfsfall. Jede Vorschubeinheit wird durch eine eigene Steuerkarte angesprochen. Damit kann in beide Richtungen unabhängig voneinander verfahren werden. Die Vorschubgeschwindigkeit ist in zwei Stufen wählbar. Um den Intensitätsverlust bei der Lichtübertragung gering zu halten und einen modularen Aufbau realisieren zu können, wurde als Übertragungsmedium zwischen Lampe und Platte ein Lichtleiter gewählt. Dieser ist in der Lage, sowohl eine als auch mehrere Wellenlängen zu übertragen. Durch den Einsatz eines optimierten Faserbündels, das mit Wasserstoff begast wurde, um die Bildung von Farbzentren zu verhindern, kann die Alterung stark verlangsamt werden. Die Dämpfung der Lichtintensität innerhalb der Faser spielt durch die Verwendung kurzer Fasern nur eine untergeordnete Rolle. Als Detektionseinheit werden Photodiodenarrays verwendet, die 256 bzw. 512 Dioden besitzen. Eingebaut wird jeweils nur das vorjustierte Array, das auf eine Platine aufgebracht ist, die die Elektronik zum Auslesen sowie die Möglichkeit zur Ansteuerung des Auslesevorganges bereits enthält. Die Minimalkonfiguration erlaubt das Verwenden eigener, für den Einsatzzweck optimierter Bauteile. Die erstellte Software verarbeitet die registrierten Daten und ordnet die Signale den entsprechenden Wellenlängen zu. Die Rohdaten werden nach der bekannten Gleichung von Kubelka und Munk in Remissionswerte umgerechnet. Ein neues Verfahren zur Glättung von zweidimensional verrauschten Daten wird eingeführt, mit Hilfe dessen die Signale in eine verwertbare Form übergeführt werden. Hierzu wird eine Regressionsrechnung in zwei Dimensionen mittels eines Polynoms durchgeführt. Die Glättungsbreite kann variabel für beide Dimensionen bestimmt werden. Die Faltungsoperation kann im Gegensatz zu bisher bekannten Verfahren auch während der Auswertung durchgeführt werden. Statische Faltungsoperatoren werden nicht mehr benötigt. Peaks werden gesucht und ihre Lage mit Hilfe einer Basisfläche korrigiert. Diese Fläche berücksichtigt Matrixeinflüsse der Platte, Schwankungen im Lichtstrom der Lampe und Änderungen der mobilen Phase während der Entwicklung. Die transformierten und geglätteten Daten werden in zwei Dateien geschrieben, die sich nur in der Art der Speicherung unterscheiden, um sie mit Fremdprogrammen weiterverarbeiten zu können. Es wird die Möglichkeit untersucht, Remissionsspektren unterschiedlicher Herkunft und UV-Spektren miteinander zu vergleichen. Um auf umfangreiche existierende UV- Spektrenkataloge zurückgreifen zu können, wird eine Möglichkeit gesucht, mit deren Hilfe die Remissionsspektren UV-Spektren zugeordnet werden können. Ein automatisiertes Vorgehen alleine reicht nicht aus, der Eingriff des Benutzers ist unerläßlich. Bei Remissionsdaten findet eine nicht reproduzierbare Verschiebung der Wellenlängen statt, die ein direktes Inbezugsetzen verhindert. Es wird ein Auftrageschema vorgestellt, das auch für quantitative Analysen 2D- entwickelter Platten anwendbar ist. Zusätzlich zu dem zu untersuchenden Gemisch werden 3 Standardgemische bekannter Konzentration und Zusammensetzung aufgetragen. Die erste Entwicklung erfolgt von gegenüberliegenden Seiten bis zur Mitte der Platte, nach Trocknen und Drehen um 90° wird die zweite Entwicklung ebenfalls beidseitig durchgeführt. So wird die Plattenoberfläche optimal ausgenutzt und die Kriterien zur quantitativen Auswertung werden erfüllt. Die Leistungsfähigkeit des neu eingeführten Glättungsalgorithmus wird gezeigt. Auf die Besonderheiten einer Auswertung anhand des Peakvolumen und nicht wie bisher anhand der Peakfläche wird eingegangen. Ein Datensatz von aufgenommenen Spektren wird nach der Verarbeitung gezeigt. Das entwickelte System aus Hard- und Software ist in der Lage, jeden Punkt auf der Platte anzusteuern und Daten zur weiteren Auswertung in genügend hoher Genauigkeit zu liefern.
Aims
Various studies have reported that young European women are more likely to develop early‐onset periodontitis compared to men. A potential explanation for the observed variations in sex and age of disease onset is the natural genetic variation within the autosomal genomes. We hypothesized that genotype‐by‐sex (G × S) interactions contribute to the increased prevalence and severity.
Materials and methods
Using the case‐only design, we tested for differences in genetic effects between men and women in 896 North‐West European early‐onset cases, using imputed genotypes from the OmniExpress genotyping array. Population‐representative 6823 controls were used to verify that the interacting variables G and S were uncorrelated in the general population.
Results
In total, 20 loci indicated G × S associations (P < 0.0005), 3 of which were previously suggested as risk genes for periodontitis (ABLIM2, CDH13, and NELL1). We also found independent G × S interactions of the related gene paralogs MACROD1/FLRT1 (chr11) and MACROD2/FLRT3 (chr20). G × S‐associated SNPs at CPEB4, CDH13, MACROD1, and MECOM were genome‐wide‐associated with heel bone mineral density (CPEB4, MECOM), waist‐to‐hip ratio (CPEB4, MACROD1), and blood pressure (CPEB4, CDH13).
Conclusions
Our results indicate that natural genetic variation affects the different heritability of periodontitis among sexes and suggest genes that contribute to inter‐sex phenotypic variation in early‐onset periodontitis.
Introduction
The term primary progressive aphasia (PPA) sums up the non‐fluent (nfv), the semantic (sv), and the logopenic (lv) variant. Up to now, there is only limited data available concerning magnetic resonance imaging volumetry to monitor disease progression.
Methods
Structural brain imaging and an extensive assessment were applied at baseline and up to 4‐year(s) follow‐up in 269 participants. With automated atlas‐based volumetry 56 brain regions were assessed. Atrophy progression served to calculate sample sizes for therapeutic trials.
Results
At baseline highest atrophy appeared in parts of the left frontal lobe for nfvPPA (–17%) and of the left temporal lobe for svPPA (–34%) and lvPPA (–24%). Severest progression within 1‐year follow‐up occurred in the basal ganglia in nfvPPA (–7%), in the hippocampus/amygdala in svPPA (–9%), and in (medial) temporal regions in lvPPA (–6%).
Conclusion
PPA presents as a left‐dominant, mostly gray matter sensitive disease with considerable atrophy at baseline that proceeds variant‐specific.
Background
With upcoming therapeutic interventions for patients with primary progressive aphasia (PPA), instruments for the follow-up of patients are needed to describe disease progression and to evaluate potential therapeutic effects. So far, volumetric brain changes have been proposed as clinical endpoints in the literature, but cognitive scores are still lacking. This study followed disease progression predominantly in language-based performance within 1 year and defined a PPA sum score which can be used in therapeutic interventions.
Methods
We assessed 28 patients with nonfluent variant PPA, 17 with semantic variant PPA, 13 with logopenic variant PPA, and 28 healthy controls in detail for 1 year. The most informative neuropsychological assessments were combined to a sum score, and associations between brain atrophy were investigated followed by a sample size calculation for clinical trials.
Results
Significant absolute changes up to 20% in cognitive tests were found after 1 year. Semantic and phonemic word fluency, Boston Naming Test, Digit Span, Token Test, AAT Written language, and Cookie Test were identified as the best markers for disease progression. These tasks provide the basis of a new PPA sum score. Assuming a therapeutic effect of 50% reduction in cognitive decline for sample size calculations, a number of 56 cases is needed to find a significant treatment effect. Correlations between cognitive decline and atrophy showed a correlation up to r = 0.7 between the sum score and frontal structures, namely the superior and inferior frontal gyrus, as well as with left-sided subcortical structures.
Conclusion
Our findings support the high performance of the proposed sum score in the follow-up of PPA and recommend it as an outcome measure in intervention studies.
Excitons in atomically thin transition-metal dichalcogenides (TMDs) have been established as an attractive platform to explore polaritonic physics, owing to their enormous binding energies and giant oscillator strength. Basic spectral features of exciton polaritons in TMD microcavities, thus far, were conventionally explained via two-coupled-oscillator models. This ignores, however, the impact of phonons on the polariton energy structure. Here we establish and quantify the threefold coupling between excitons, cavity photons, and phonons. For this purpose, we employ energy-momentum-resolved photoluminescence and spatially resolved coherent two-dimensional spectroscopy to investigate the spectral properties of a high-quality-factor microcavity with an embedded WSe\(_2\) van-der-Waals heterostructure at room temperature. Our approach reveals a rich multi-branch structure which thus far has not been captured in previous experiments. Simulation of the data reveals hybridized exciton-photon-phonon states, providing new physical insight into the exciton polariton system based on layered TMDs.
Background
The oral mucosa has an important role in maintaining barrier integrity at the gateway to the gastrointestinal and respiratory tracts. Smoking is a strong environmental risk factor for the common oral inflammatory disease periodontitis and oral cancer. Cigarette smoke affects gene methylation and expression in various tissues. This is the first epigenome-wide association study (EWAS) that aimed to identify biologically active methylation marks of the oral masticatory mucosa that are associated with smoking.
Results
Ex vivo biopsies of 18 current smokers and 21 never smokers were analysed with the Infinium Methylation EPICBeadChip and combined with whole transcriptome RNA sequencing (RNA-Seq; 16 mio reads per sample) of the same samples. We analysed the associations of CpG methylation values with cigarette smoking and smoke pack year (SPY) levels in an analysis of covariance (ANCOVA). Nine CpGs were significantly associated with smoking status, with three CpGs mapping to the genetic region of CYP1B1 (cytochrome P450 family 1 subfamily B member 1;best p=5.5x10(-8)) and two mapping to AHRR (aryl-hydrocarbon receptor repressor; best p=5.9x10(-9)). In the SPY analysis, 61 CpG sites at 52 loci showed significant associations of the quantity of smoking with changes in methylation values. Here, the most significant association located to the gene CYP1B1, with p=4.0x10(-10). RNA-Seq data showed significantly increased expression of CYP1B1 in smokers compared to non-smokers (p=2.2x10(-14)), together with 13 significantly upregulated transcripts. Six transcripts were significantly downregulated. No differential expression was observed for AHRR. In vitro studies with gingival fibroblasts showed that cigarette smoke extract directly upregulated the expression of CYP1B1.
Conclusion
This study validated the established role of CYP1B1 and AHRR in xenobiotic metabolism of tobacco smoke and highlights the importance of epigenetic regulation for these genes. For the first time, we give evidence of this role for the oral masticatory mucosa.
Strong light matter coupling between excitons and microcavity photons, as described in the framework of cavity quantum electrodynamics, leads to the hybridization of light and matter excitations. The regime of collective strong coupling arises, when various excitations from different host media are strongly coupled to the same optical resonance. This leads to a well-controllable admixture of various matter components in three hybrid polariton modes. Here, we study a cavity device with four embedded GaAs quantum wells hosting excitons that are spectrally matched to the A-valley exciton resonance of a MoSe\(_{2}\) monolayer. The formation of hybrid polariton modes is evidenced in momentum resolved photoluminescence and reflectivity studies. We describe the energy and k-vector distribution of exciton-polaritons along the hybrid modes by a thermodynamic model, which yields a very good agreement with the experiment.
Single nucleotide polymorphisms (SNPs) in the ADGRL3 gene have been significantly associated with the development of ADHD, the aetiology of which remains poorly understood. The rs1397547 SNP has additionally been associated with significantly altered ADGRL3 transcription. We therefore generated iPSCs from two wild type ADHD patients, and two ADHD patients heterozygous for the risk SNP. With this resource we aim to facilitate further investigation into the complex and heterogenous pathology of ADHD. Furthermore, we demonstrate the feasibility of using magnetic activated cell sorting to allow the unbiased selection of fully reprogrammed iPSCs.
Alien limb phenomenon is a rare syndrome associated with a feeling of non-belonging and disowning toward one's limb. In contrast, anarchic limb phenomenon leads to involuntary but goal-directed movements. Alien/anarchic limb phenomena are frequent in corticobasal syndrome (CBS), an atypical parkinsonian syndrome characterized by rigidity, akinesia, dystonia, cortical sensory deficit, and apraxia. The structure function relationship of alien/anarchic limb was investigated in multi centric structural magnetic resonance imaging (MRI) data. Whole-group and single subject comparisons were made in 25 CBS and eight CBS-alien/anarchic limb patients versus controls. Support vector machine was used to see if CBS with and without alien/anarchic limb could be distinguished by structural MRI patterns. Whole-group comparison of CBS versus controls revealed asymmetric frontotemporal atrophy. CBS with alien/anarchic limb syndrome versus controls showed frontoparietal atrophy including the supplementary motor area contralateral to the side of the affected limb. Exploratory analysis identified frontotemporal regions encompassing the pre-/and postcentral gyrus as compromised in CBS with alien limb syndrome. Classification of CBS patients yielded accuracies of 79%. CBS-alien/anarchic limb syndrome was differentiated from CBS patients with an accuracy of 81%. Predictive differences were found in the cingulate gyrus spreading to frontomedian cortex, postcentral gyrus, and temporoparietoocipital regions. We present the first MRI-based group analysis on CBS-alien/anarchic limb. Results pave the way for individual clinical syndrome prediction and allow understanding the underlying neurocognitive architecture. (C) 2019 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Genetic and molecular mechanisms that play a causal role in mental illnesses are challenging to elucidate, particularly as there is a lack of relevant in vitro and in vivo models. However, the advent of induced pluripotent stem cell (iPSC) technology has provided researchers with a novel toolbox. We conducted a systematic review using the PRISMA statement. A PubMed and Web of Science online search was performed (studies published between 2006–2020) using the following search strategy: hiPSC OR iPSC OR iPS OR stem cells AND schizophrenia disorder OR personality disorder OR antisocial personality disorder OR psychopathy OR bipolar disorder OR major depressive disorder OR obsessive compulsive disorder OR anxiety disorder OR substance use disorder OR alcohol use disorder OR nicotine use disorder OR opioid use disorder OR eating disorder OR anorexia nervosa OR attention-deficit/hyperactivity disorder OR gaming disorder. Using the above search criteria, a total of 3515 studies were found. After screening, a final total of 56 studies were deemed eligible for inclusion in our study. Using iPSC technology, psychiatric disease can be studied in the context of a patient’s own unique genetic background. This has allowed great strides to be made into uncovering the etiology of psychiatric disease, as well as providing a unique paradigm for drug testing. However, there is a lack of data for certain psychiatric disorders and several limitations to present iPSC-based studies, leading us to discuss how this field may progress in the next years to increase its utility in the battle to understand psychiatric disease.
The neuronal RNA-binding protein Ptbp2 regulates neuronal differentiation by modulating alternative splicing programs in the nucleus. Such programs contribute to axonogenesis by adjusting the levels of protein isoforms involved in axon growth and branching. While its functions in alternative splicing have been described in detail, cytosolic roles of Ptbp2 for axon growth have remained elusive. Here, we show that Ptbp2 is located in the cytosol including axons and growth cones of motoneurons, and that depletion of cytosolic Ptbp2 affects axon growth. We identify Ptbp2 as a major interactor of the 3’ UTR of Hnrnpr mRNA encoding the RNA-binding protein hnRNP R. Axonal localization of Hnrnpr mRNA and local synthesis of hnRNP R protein are strongly reduced when Ptbp2 is depleted, leading to defective axon growth. Ptbp2 regulates hnRNP R translation by mediating the association of Hnrnpr with ribosomes in a manner dependent on the translation factor eIF5A2. Our data thus suggest a mechanism whereby cytosolic Ptbp2 modulates axon growth by fine-tuning the mRNA transport and local synthesis of an RNA-binding protein.